Smoking cessation can improve quality of life among COPD patients: Validation of the clinical COPD questionnaire into Greek

BMC Pulmonary Medicine

Volumn 11, Issue , 2011, Pages

  Papadopoulos, George ^a,b   Vardavas, Constantine I ^b   Limperi, Maria ^a   Linardis, Apostolos ^c   Georgoudis, George ^d   Behrakis, Panagiotis ^a,b  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b Hellenic Cancer Society Athens   (Greece)

^c National Centre of Social Research   (Greece)

^d UNIVERSITY OF WEST ATTICA   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL COPD QUESTIONNAIRE; CONTROLLED STUDY; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; GREECE; HUMAN; INTERNAL VALIDITY; MAJOR CLINICAL STUDY; MALE; QUALITY OF LIFE; QUESTIONNAIRE; SCORING SYSTEM; SHORT FORM 12; SMOKING CESSATION; TEST RETEST RELIABILITY; VALIDATION STUDY; LANGUAGE; LUNG FUNCTION TEST; MIDDLE AGED; PATHOPHYSIOLOGY; PSYCHOLOGICAL ASPECT; REPRODUCIBILITY;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; GREECE; HUMANS; LANGUAGE; MALE; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITY OF LIFE; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; RESPIRATORY FUNCTION TESTS; SMOKING CESSATION;

EID: 79951955171     PISSN: None     EISSN: 14712466     Source Type: Journal    
DOI: 10.1186/1471-2466-11-13     Document Type: Article

References (28)

1. Celli BR, MacNee W, . committee members Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 2004, 23:932-946. 10.1183/09031936.04.00014304, 15219010, committee members.
2. European Respiratory Society (ERS), European Lung Foundation (ELF). 2003, European Lung White Book.
3. World Health Organization. Chronic Respiratory Diseases. 2010, http://www.who.int/respiratory/copd/burden/en/index.html
4. Pauwels RA, Buist AS, Calverley PM, Jenkins CR, Hurd SS, . GOLD Scientific Committee Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Pulmonary Disease (GOLD). Am J Respir Crit Care Med 2001, 163(SUPPL. 5):1256-1276. GOLD Scientific Committee.
5. Lopez AD, Shibuya K, Rao C, Mathers CD, Hansell AL, Held LS, Schmid V, Buist S. Chronic obstructive pulmonary disease: current burden and future projections. Eur Respir J 2006, 27(SUPPL. 2):397-412. 10.1183/09031936.06.00025805, 16452599.
6. Department of Health and Human Services The Health Consequences of Involuntary Exposure to Tobacco Smoke: A Report of the Surgeon General. 2006, Washington, DC, US, Last assessed 3/6/2010, Department of Health and Human Services., http://www.surgeongeneral.gov/library/smokeexposure/index.html
7. Eisner MD, Balmes J, Katz BP, Trupin L, Yelin E, Blanc P. Lifetime environmental tobacco smoke exposure and the risk of chronic obstructive pulmonary disease. Environ Health Perspect 2005, 4:7-15.
8. Siafakas NM, Vermeire P, Pride NB, Paoletti P, Gibson J, Howard P, Yernault JC, Decramer M, Higenbottam T, Postma DS, Rees J, . on behalf of the Task Force Optimal assessment and management of chronic obstructive pulmonary disease (COPD) The European Respiratory Society Task Force. Eur Respir J 1995, 8(SUPPL. 8):1398-420. 10.1183/09031936.95.08081398, 7489808, on behalf of the Task Force.
9. Anthonisen NR, Connett JE, Kiley JP, Altose MD, Bailey WC, Buist AS, et al. Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study. JAMA 1994, 272(SUPPL. 19):1497-505. 10.1001/jama.272.19.1497, 7966841.
10. Fabri LM, Hurd SS, . for the GOLD Scientific Committee Global strategy for the diagnosis, management and prevention of COPD: 2003 update. Eur Respir J 2003, 22:1-2. 10.1183/09031936.03.00063703, 12882441, for the GOLD Scientific Committee.
11. Wijkstra PJ, Van Altena R, Kraan J, Otten V, Postma DS, Koeter GH. Quality of life in patients with chronic obstructive pulmonary disease improves after rehabilitation at home. Eur Respir J 1995, 7(SUPPL. 2):269-73.
12. Spencer S, Calverly PM, Sherwood-Burge P, Jones PW. Health Status eterioration in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001, 163(SUPPL. 1):122-8.
13. Van der Molen T, Willemse BWM, Schokker S, ten Haken NHT, Postma DS, Juniper EF. Development, validity and responsiveness of the Clinical COPD Questionnaire. Health Qual Life Outcomes 2003, 1:13. 10.1186/1477-7525-1-13, 156640, 12773199.
14. Mannino DM, Ford ES, Redd SC. Obstructive and restrictive lung disease and markers of inflammation data from the Third National Health and Nutrition Examination. Am J Med 2003, 114(SUPPL. 9):758-62. 10.1016/S0002-9343(03)00185-2, 12829203.
15. Pellegrino R, Viegi G, Brusasco V, Crapo RO, Burgos F, Casaburi R, Coates A, van der Grinten CP, Gustafsson P, Hankinson J, Jensen R, Johnson DC, MacIntyre N, McKay R, Miller MR, Navajas D, Pedersen OF, Wanger J. Interpretative strategies for lung function tests. Eur Respir J 2005, 26(SUPPL. 5):948-68. 10.1183/09031936.05.00035205, 16264058.
16. Ware JE, Kosinski M, Keller SD. A 12-Item Short-Form Health Survey: Construction of scales and preliminary tests of reliability and validity. Medical Care 1996, 34(SUPPL. 3):220-233. 10.1097/00005650-199603000-00003, 8628042.
17. Damato S, Bonatti C, Frigo V, Pappagallo S, Raccanelli R, Claudio R, Francesco R. Validation of the Clinical COPD. Health and Quality of Life Outcomes 2005, 3:9. 10.1186/1477-7525-3-9, 549036, 15698477.
18. Björn S, Nokela M, Ehrs P, Paul H, Eva Wikström J. Validation of the Clinical COPD (CCQ) in primary care. Health and Quality of Life Outcomes 2009, 7:26. 2666647, 19320988.
19. Elisabeth S, Lindberg A, Jansson S, Eva R, Svensson K, Andersson F, Claes-Göran L, Lundbäck B. Health-related quality of life is related to COPD disease severity. Health and Quality of Life Outcomes 2005, 3:56. 10.1186/1477-7525-3-56, 1215504, 16153294.
20. Glaab T, Vogelmeier C, Buhl R. Outcome measures in chronic obstructive pulmonary disease (COPD): strengths and limitations. Respiratory Research 2010, 11:79. 10.1186/1465-9921-11-79, 2902430, 20565728.
21. Jones PW. Quality of life measurement for patients with diseases of the airways. Thorax 1991, 46:676-682. 10.1136/thx.46.9.676, 463372, 1835178.
22. Lapperre TS, Sont JK, van Schadewijk A, Gosman MM, Postma DS, Bajema IM, Timens W, Mauad T, Hiemstra PS, . GLUCOLD Study Group Smoking cessation and bronchial epithelial remodelling in COPD: a cross-sectional study. Respir Res 2007, 8:85. 10.1186/1465-9921-8-85, 2214729, 18039368, GLUCOLD Study Group.
23. Johnson HM, Gossett LK, Piper ME, Aeschlimann SE, Korcarz CE, Baker TB, Fiore MC, Stein JH. Effects of Smoking and Smoking Cessation on Endothelial Function 1-Year Outcomes From a Randomized Clinical Trial. J Am Coll Cardiol 2010, 55:1988-1995. 10.1016/j.jacc.2010.03.002, 20236788.
24. Gratziou C. Respiratory, cardiovascular and other physiological consequences of smoking cessation. Curr Med Res Opin 2009, 25(SUPPL. 2):535-45. 10.1185/03007990802707642, 19193001.
25. Domagala-Kulawik J. Effects of cigarette smoke on the lung and systemic immunity. J Physiol Pharmacol 2008, 59(SUPPL. 6):19-34.
26. Tsoumakidou M, Bouloukaki I, Koutala H, Kouvidi K, Mitrouska I, Zakynthinos S, Tzanakis N, Jeffery PK, Siafakas NM. Decreased sputum mature dendritic cells in healthy smokers and patients with chronic obstructive pulmonary disease. Int Arch Allergy Immunol 2009, 150(SUPPL. 4):389-97. 10.1159/000226240, 19571571.
27. Bagaitkar J, Demuth DR, Scott DA. Tobacco use increases susceptibility to bacterial infection. Tob Induc Dis 2008, 4:12. 10.1186/1617-9625-4-12, 2628337, 19094204.
28. Shavelle RM, Paculdo DR, Kush SJ, Mannino DM, Strauss DJ. Life expectancy and years of life lost in chronic obstructive pulmonary disease: findings from the NHANES III Follow-up study. Int J Chron Obstruct Pulmon Dis 2009, 4:137-148. 2672796, 19436692.